Changeflow GovPing Healthcare Status Sensing Systems for Connected Injection ...
Routine Rule Added Final

Status Sensing Systems for Connected Injection Device EP4257167A2

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

EPO published patent application EP4257167A2 for Eli Lilly and Company's status sensing systems for connected injection devices. The application, filed by inventors PATEL, SOMLAI, and WIESLER, covers injection devices with sensing technology for monitoring injection status. The patent designates all EU member states plus extension states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

EPO published patent application EP4257167A2 for status sensing systems in connected injection devices, establishing the filing date and making the technical disclosure publicly available. The application covers A61M-classified injection devices with integrated sensing technology.

Pharmaceutical and medical device companies developing injection delivery systems should review this publication to assess potential freedom-to-operate implications. Third parties may now examine the claims for competitive intelligence purposes.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

STATUS SENSING SYSTEMS FOR CONNECTED INJECTION DEVICE

Publication EP4257167A2 Kind: A2 Apr 08, 2026

Applicants

Eli Lilly and Company

Inventors

PATEL, Hemant Thakorbhai, SOMLAI, Louis Stevens, WIESLER, Adam Nathaniel

IPC Classifications

A61M 5/20 20060101AFI20231128BHEP A61M 5/24 20060101ALI20231128BHEP A61M 5/32 20060101ALI20231128BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4257167A2
Docket
EP4257167

Who this affects

Applies to
Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing IP registration
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!